Skip to content
healthcare.dev
Get a free key

OCREVUS

NDC 50242-150, ocrelizumab, injection, from Genentech, Inc..

Product NDC
50242-150
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761053
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCRELIZUMAB300 mg/10mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Antibodies, Monoclonal, Humanized [CS]; CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
50242-150-01502420150011 VIAL, SINGLE-USE in 1 CARTON (50242-150-01) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9da42362-3bb5-4b83-b4bb-b59fd4e55f0d

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-150

Use it

Look up 50242-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.